Ibutamoren MK-677
AED330
Enhanced Athlete MK-677 contains 10mg x 60 capsules. MK-677 is not a SARM but is classed in the same category as an investigational drug. Ibutamoren (INN) (developmental code names MK-677, MK-0677, L-163,191; former tentative brand name Oratrope) is a potent, long-acting, orally-active, selective, and non-peptide agonist of the ghrelin receptor and a growth hormone secretagogue, mimicking the growth hormone (GH)-stimulating action of the endogenous hormone ghrelin.
ChemSpider ID: 154975
Formula: C27H36N4O5S
Other names: MK-677; MK-0677; L-163,191; Oratrope
PubChem CID: 9939050
Molar mass: 528.67 g·mol−1
WHAT IS ENHANCED ATHLETE MK-677?
Ibutamoren has been shown to sustain activation of the GH–IGF-1 axis and to increase lean body mass with no change in total fat mass or visceral fat. It is under investigation as a potential treatment for reduced levels of these hormones, such as in children or elderly adults with growth hormone deficiency, and human studies have shown it to increase both muscle mass and bone mineral density, making it a promising potential therapy for the treatment of frailty in the elderly. As of June 2017, ibutamoren is in the preclinical stage of development for growth hormone deficiency.
THIS PRODUCT IS SOLD FOR RESEARCH PURPOSES ONLY. SARMSHERO.COM DOES NOT ENDORSE THE USE OF SARMS FOR HUMAN CONSUMPTION, SARMS ARE NOT DIETARY SUPPLEMENTS.
Enhanced Athlete MK-677 contains 10mg x 60 capsules. MK-677 is not a SARM but is classed in the same category as an investigational drug. Ibutamoren (INN) (developmental code names MK-677, MK-0677, L-163,191; former tentative brand name Oratrope) is a potent, long-acting, orally-active, selective, and non-peptide agonist of the ghrelin receptor and a growth hormone secretagogue, mimicking the growth hormone (GH)-stimulating action of the endogenous hormone ghrelin.
ChemSpider ID: 154975
Formula: C27H36N4O5S
Other names: MK-677; MK-0677; L-163,191; Oratrope
PubChem CID: 9939050
Molar mass: 528.67 g·mol−1
WHAT IS ENHANCED ATHLETE MK-677?
Ibutamoren has been shown to sustain activation of the GH–IGF-1 axis and to increase lean body mass with no change in total fat mass or visceral fat. It is under investigation as a potential treatment for reduced levels of these hormones, such as in children or elderly adults with growth hormone deficiency, and human studies have shown it to increase both muscle mass and bone mineral density, making it a promising potential therapy for the treatment of frailty in the elderly. As of June 2017, ibutamoren is in the preclinical stage of development for growth hormone deficiency.
THIS PRODUCT IS SOLD FOR RESEARCH PURPOSES ONLY. SARMSHERO.COM DOES NOT ENDORSE THE USE OF SARMS FOR HUMAN CONSUMPTION, SARMS ARE NOT DIETARY SUPPLEMENTS.
English
Arabic